Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: OFS + Anastrozole|DRUG: OFS + Exemestane
Sponsor: Shanghai Jiao Tong University School of Medicine